Form 4 for MGNX MACROGENICS INC
Accepted 2024-02-26 00:00:00 ET · period of report 2024-02-22 · accession 0001125345-24-000046 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-26 | 2024-02-22 | MGNX | Bonvini Ezio | SVP, CSO, Research | F - Tax | $17.11 | -9,366 | 100.9K | -8% | -$160.3K |
| D | 2024-02-26 | 2024-02-22 | MGNX | Bonvini Ezio | SVP, CSO, Research | M - OptEx | $0.00 | +28.1K | 110.3K | +34% | $0 |
| D | 2024-02-26 | 2024-02-22 | MGNX | Bonvini Ezio | SVP, CSO, Research | M - OptEx | $0.00 | -28.1K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-22 | F | D | 9,366 | $17.11 | 100,892 | D | — | — | |
| 2 | Common | Common Stock | 2024-02-22 | M | A | 28,125 | $0.00 | 110,258 | D | — | — | (F1) On February 22, 2022 the reporting person was granted 37,500 restricted stock units, 25% of which vested on February 22, 2023 and 75% vested on February 22, 2024. Restricted stock units convert into the Company's stock on a one-for-one basis. |
| 3 | Derivative | Restricted Stock Unit | 2024-02-22 | M | D | 28,125 | $0.00 | 0 | D | $0.00 · — to — | 28,125 Common Stock | (F1) On February 22, 2022 the reporting person was granted 37,500 restricted stock units, 25% of which vested on February 22, 2023 and 75% vested on February 22, 2024. Restricted stock units convert into the Company's stock on a one-for-one basis. |